Inflammatory Bowel Disease (IBD), which includes Crohn's Disease and Ulcerative Colitis, is a group of chronic inflammatory conditions affecting the gastrointestinal tract with unknown aetiology and autoimmune pathogenesis. To effectively manage these complex diseases, our Foundation has implemented an organizational model that standardizes shared criteria for the comprehensive care of IBD patients. Given the complexity of these conditions, the Clinical Care Pathway dedicated to IBD patients is based on a multidisciplinary approach. This involves collaboration among various specialists, including gastroenterologists, pathologists, rheumatologists, ophthalmologists, dermatologists, nursing staff, radiologists, surgeons, psychologists, and nutritionists. This team works together to ensure holistic patient care and management of chronic conditions, aiming to improve the overall quality of life for our patients.
Irritable Bowel Syndrome (IBS), also known as spastic colon or irritable colon, is a common gastrointestinal disorder characterized by a combination of intestinal symptoms that primarily affect the colon. IBS often involves chronic abdominal pain, discomfort, and altered bowel habits, such as constipation, diarrhoea, or a mix of both. Despite its prevalence, IBS is frequently underestimated in terms of its social impact. At our Digestive Disease Center (CEMAD), we emphasize a holistic, multidisciplinary approach to patient care. This includes studying the patient's microbiota, nutritional habits, and psychological state. By integrating these aspects, we aim to provide comprehensive treatment and improve the overall quality of life for our patients.
